Book Value per Share: Benitec Biopharma (BNTC)

Graphic logo of Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Inc. (BNTC) is an Australian biotech startup where experienced management relies on external funding and subsidies. The asset's market dynamics on the GURU.Markets platform show a value of 5.10. Benitec Biopharma Inc. (BNTC) generates revenue through partnerships and grants while developing gene silencing methods. However, relying exclusively on a single platform to combat dysphagia creates critical risks for investors.

Benitec (BNTC) Equity per Share: for the period 07/04/2022 - 10/27/2026

Summary analytical data breakdowns for benitec.com (BNTC)

- price and consensus price forecast:
Stock Quotes Benitec|BNTC - Analyst Forecast Prices
- market capitalization data:
Market Capitalization Benitec Biopharma Inc.|BNTC - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Benitec Biopharma|BNTC - Accounting Capitalization|Market Value to Book Value Ratio benitec.com|BNTC - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Benitec Biopharma Inc.|BNTC - Long-Term Debt to Capital|Short-Term Debt to Capital Benitec Biopharma|BNTC - Company Debts|Debts to Book Capitalization Benitec Biopharma Inc.
Analysis of all company metrics:Benitec, BNTC
Manufactured products of benitec.com

Benitec Biopharma Inc. (BNTC) development of innovative gene silencing methods requires colossal resources to secure patents and navigate clinical trials. This metric is calculated as the difference between all assets and liabilities divided by the number of shares, reflecting the real value of an investor's stake; analyzing the historical change in book value per share allows for an assessment of the company's financial stability in the face of high technological risks.

Competitor analysis for Benitec Biopharma Inc.

Accounting Value per Share Tempus AI, Inc. TEM|QGEN - Book Price of a Share|IONS (Ionis Pharmaceuticals) - Book Value per Share|repligen.com (RGEN) - Accounting Value per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|Book Value per Share sarepta.com SRPT|TWST - Book Value per Share|TXG - Net Assets per Single Share|Book Value per Share NTLA|STOK (Stoke Corp) - Net Asset Value per Share|Net Assets per Single Share BioLife Solutions, Inc. (BLFS)|Equity per Share wavelifesciences.com|MAZE (Maze Therapeutics) - Book Value per Share|Net Assets per Share Sionna Therapeutics, Inc. SION|Accounting Value per Share Prime Medicine Corp (PRME)|Book Price of a Share Taysha Corp TSHA|QURE (uniQure N.V.) - Book Value per Share|MGTX - Net Asset Value per Share|RGNX (REGENXBIO) - Book Value per Share|Accounting Value per Share Solid Biosciences Inc|OCGN - Accounting Value per Share|Accounting Value of a Share PacBio Corp|Book Value per Share Design Therapeutics (DSGN)|Net Assets per Single Share rocketpharma.com (RCKT)|Book Value per Share FDMT|Lexeo Therapeutics Inc. - Net Assets per Share|KRRO (Korro Bio, Inc) - Net Assets per Single Share|EDIT: Net Asset Value per Share|Net Assets per Single Share Silence Therapeutics (SLN)|ProQR Therapeutics (PRQR) - Share Book Value|CDXS - Book Value per Share|Accounting Value of a Share Sangamo Therapeutics Inc.|Book Value per Share NAUT|Book Value per Share MGX (Metagenomi Therapeutics)|Net Assets per Single Share Precision BioSciences, Inc.|Generation Bio Co - Accounting Value of a Share|BOLD: Net Assets per Single Share|XCUR - Accounting Value per Share|IMNN: Book Value per Share|Book Value per Share Phio Pharmaceuticals Corp.|MBIO - Accounting Value per Share|Accounting Value of a Share TransCode|BNGO (Bionano Genomics, Inc.) - Book Value per Share|Net Assets per Share APDN (Applied DNA Sciences Inc)|BLUE - Net Assets per Single Share|Equity per Share ImmunoPrecise Antibodies Ltd IPA|OMGA: Book Value per Share|singulargenomics.com (OMIC) - Accounting Value per Share|Regulus Therapeutics Inc. - Accounting Value per Share|Syros Pharmaceuticals Inc. (SYRS) - Net Assets per Share|Book Value per Share Codex DNA|Net Assets per Single Share TCON|Net Assets per Single Share Unity Biotechnology UBX